2614 PUBLICATIONS
ANNÉE
JOURNAL
PREMIER AUTEUR
TITRE
ANNÉE2023
JOURNALMolecular pharmaceutics
PREMIER AUTEURAlmeida ER
TITREModeling the Cellular Uptake of Functionalized Carbon Nanohorns Loaded with Cisplatin through a Breast Cancer Cell Membrane.
ANNÉE2023
JOURNALInternational journal of public health
PREMIER AUTEURPozet A
TITREQuality of Life and Needs in Caregivers: Results From the Prospective Multicentric Open-Label Randomized Study of Informal Caregivers of Elderly Patients.
ANNÉE2023
JOURNALJournal of clinical oncology : official journal of the American Society of Clinical Oncology
PREMIER AUTEURKurtz JE
TITREAtezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial.
ANNÉE2023
JOURNALLangenbeck's archives of surgery
PREMIER AUTEURAddeo P
TITRESequential Y liver radioembolization and portal vein embolization: an additional strategy to downstage liver tumors and to enhance liver hypertrophy before major hepatectomies.
ANNÉE2023
JOURNALOncogene
PREMIER AUTEUREl Baba R
TITREPolyploidy, EZH2 upregulation, and transformation in cytomegalovirus-infected human ovarian epithelial cells.
ANNÉE2023
JOURNALWorld neurosurgery
PREMIER AUTEURTodeschi J
TITRESecond Cancer affecting the Central Nervous System: Systematic Literature Review Exploring the Link between Malignant Melanoma and Glioblastoma.
ANNÉE2023
JOURNALJournal of the European Academy of Dermatology and Venereology : JEADV
PREMIER AUTEURKhelef K
TITREDuration of treatment with cemiplimab in advanced cutaneous squamous cell carcinoma in complete response : Real-life study.
ANNÉE2023
JOURNALEuropean journal of cancer (Oxford, England : 1990)
PREMIER AUTEURBaudry E
TITREEfficacy and safety of cabozantinib rechallenge in metastatic renal cell carcinoma: A retrospective multicentric study.
ANNÉE2023
JOURNALJournal of neuroradiology = Journal de neuroradiologie
PREMIER AUTEURAlonso SM
TITREIs non-contrast MRI sufficient to detect meningioma residue after surgery ?
ANNÉE2023
JOURNALImmunological reviews
PREMIER AUTEURGhiringhelli F
TITREUsing immunogenic cell death to improve anticancer efficacy of immune checkpoint inhibitors: From basic science to clinical application.

Retrouvez aussi

Personnes
Equipes
Plateformes
Unités de recherche, établissements
Projets de recherche
Publications scientifiques